Clinical and Biochemical Markers of Cardiovascular Structure and Function in Women with the Metabolic Syndrome

American Journal of Cardiology

Volumn 116, Issue 11, 2015, Pages 1705-1710

  Velarde, Gladys P ^a   Sherazi, Saadia ^b   Kraemer, Dale F ^a,b   Bravo Jaimes, Katia ^a   Butterfield, Ryan ^a,c   Amico, Tonja ^b   Steinmetz, Sherry D ^b   Guzman, Maricela ^b   Martin, Dale ^b   Dodani, Sunita ^a   Smith, Brian H ^b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^c JOHNSON AND JOHNSON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; BIOCHEMICAL MARKER; C REACTIVE PROTEIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROCHLOROTHIAZIDE; INTERCELLULAR ADHESION MOLECULE 1; LEPTIN; LISINOPRIL; LOSARTAN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MYELOPEROXIDASE; PLASMINOGEN ACTIVATOR; PLASMINOGEN ACTIVATOR INHIBITOR 1; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN; 2-(2,6-DICHLORO-4-((3-FURAN-2-YLACRYLOYLAMINO)METHYL)BENZOYLAMINO)-3-((THIAZOLIDINE-4-CARBONYL)AMINO)PROPIONIC ACID; ACRYLAMIDE DERIVATIVE; APOLIPOPROTEIN A; BETA ALANINE; PEROXIDASE;

ADULT; AGED; ARTERIAL WALL THICKNESS; ARTICLE; CARDIOVASCULAR SYSTEM; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; HEART LEFT VENTRICLE MASS; HEART LEFT VENTRICLE WALL; HEART VENTRICLE SEPTUM; HUMAN; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; PLATELET REACTIVITY; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; ADOLESCENT; ANALOGS AND DERIVATIVES; BLOOD; BLOOD PRESSURE; COMPARATIVE STUDY; ECHOGRAPHY; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PILOT STUDY; YOUNG ADULT;

ACRYLAMIDES; ADOLESCENT; ADULT; AGED; APOLIPOPROTEINS A; APOLIPOPROTEINS B; BETA-ALANINE; BLOOD PRESSURE; C-REACTIVE PROTEIN; CAROTID INTIMA-MEDIA THICKNESS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LEPTIN; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PEROXIDASE; PILOT PROJECTS; PLASMINOGEN ACTIVATOR INHIBITOR 1; WAIST CIRCUMFERENCE; YOUNG ADULT;

EID: 84947331047     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2015.09.010     Document Type: Article

References (22)

1. S. Mottillo, K.B. Filion, J. Genest, L. Joseph, L. Pilote, P. Poirier, S. Rinfret, E.L. Schiffrin, and M.J. Eisenberg The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis J Am Coll Cardiol 56 2010 1113 1132
2. A.S. Gami, B.J. Witt, D.E. Howard, P.J. Erwin, L.A. Gami, V.K. Somers, and V.M. Montori Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies J Am Coll Cardiol 49 2007 403 414
3. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel iii) JAMA 285 2001 2486 2497
4. S.M. Grundy, J.I. Cleeman, S.R. Daniels, K.A. Donato, R.H. Eckel, B.A. Franklin, D.J. Gordon, R.M. Krauss, P.J. Savage, S.C. Smith Jr., J.A. Spertus, and F. Costa Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement Circulation 112 2005 2735 2752
5. A. Galassi, K. Reynolds, and J. He Metabolic syndrome and risk of cardiovascular disease: a meta-analysis Am J Med 119 2006 812 819
6. N. Ayalon, D.M. Gopal, D.M. Mooney, J.S. Simonetti, J.R. Grossman, A. Dwivedi, C. Donohue, A.J. Perez, J. Downing, N. Gokce, E.J. Miller, C.S. Liang, C.M. Apovian, W.S. Colucci, and J.E. Ho Preclinical left ventricular diastolic dysfunction in metabolic syndrome Am J Cardiol 114 2014 838 842
7. B. Aijaz, K.A. Ammar, F. Lopez-Jimenez, M.M. Redfield, S.J. Jacobsen, and R.J. Rodeheffer Abnormal cardiac structure and function in the metabolic syndrome: a population-based study Mayo Clin Proc 83 2008 1350 1357
8. M. Chinali, R.B. Devereux, B.V. Howard, M.J. Roman, J.N. Bella, J.E. Liu, H.E. Resnick, E.T. Lee, L.G. Best, and G. de Simone Comparison of cardiac structure and function in American Indians with and without the metabolic syndrome (the Strong Heart Study) Am J Cardiol 93 2004 40 44
9. S.H. Park, C. Shub, T.P. Nobrega, K.R. Bailey, and J.B. Seward Two-dimensional echocardiographic calculation of left ventricular mass as recommended by the American Society of Echocardiography: correlation with autopsy and M-mode echocardiography J Am Soc Echocardiogr 9 1996 119 128
10. R. Tibshirani Regression shrinkage and selection via the lasso J R Stat Soc Ser B 58 1996 267 288
11. H. Akaike A new look at the statistical model identification IEEE Trans Automatic Control 1974 716 723
12. P.M. Ridker, N. Rifai, N.R. Cook, G. Bradwin, and J.E. Buring Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women JAMA 294 2005 326 333
13. C.M. Ballantyne, and R.C. Hoogeveen Role of lipid and lipoprotein profiles in risk assessment and therapy Am Heart J 146 2003 227 233
14. F.H. Chiu, C.H. Chuang, W.C. Li, Y.M. Weng, W.C. Fann, H.Y. Lo, C. Sun, and S.H. Wang The association of leptin and C-reactive protein with the cardiovascular risk factors and metabolic syndrome score in Taiwanese adults Cardiovasc Diabetol 11 2012 40
15. S.M. Grundy Inflammation, hypertension, and the metabolic syndrome JAMA 290 2003 3000 3002
16. A. Azevedo, P. Bettencourt, P.B. Almeida, A.C. Santos, C. Abreu-Lima, H.W. Hense, and H. Barros Increasing number of components of the metabolic syndrome and cardiac structural and functional abnormalities - cross-sectional study of the general population BMC Cardiovasc Disord 7 2007 17
17. J.O. Toikka, H. Laine, M. Ahotupa, A. Haapanen, J.S. Viikari, J.J. Hartiala, and O.T. Raitakari Increased arterial intima-media thickness and in vivo LDL oxidation in young men with borderline hypertension Hypertension 36 2000 929 933
18. A. Adolphe, L.S. Cook, and X. Huang A cross-sectional study of intima-media thickness, ethnicity, metabolic syndrome, and cardiovascular risk in 2268 study participants Mayo Clin Proc 84 2009 221 228
19. A.M. Sironi, A. Gastaldelli, A. Mari, D. Ciociaro, V. Positano, E. Buzzigoli, S. Ghione, S. Turchi, M. Lombardi, and E. Ferrannini Visceral fat in hypertension: influence on insulin resistance and beta-cell function Hypertension 44 2004 127 133
20. S.B. Wheatcroft, I.L. Williams, A.M. Shah, and M.T. Kearney Pathophysiological implications of insulin resistance on vascular endothelial function Diabet Med 20 2003 255 268
21. G.M. Reaven, H. Lithell, and L. Landsberg Hypertension and associated metabolic abnormalities-the role of insulin resistance and the sympathoadrenal system N Engl J Med 334 1996 374 381
22. E.J. Jacobs, C.C. Newton, Y. Wang, A.V. Patel, M.L. McCullough, P.T. Campbell, M.J. Thun, and S.M. Gapstur Waist circumference and all-cause mortality in a large US cohort Arch Intern Med 170 2010 1293 1301